MyFinsight
Home
Compare
About
Recent SEC Filings
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
ALLURION TECHNOLOGIES, INC. (ALURW)
ALLURION TECHNOLOGIES, INC. (ALURW)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
-$355K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Warrant inducement expense
Proceeds from warrant inducement...
Change in fair value of revenue ...
Others
Negative Cash Flow Breakdown
Change in fair value of warrant ...
General and administrative
Other segment items
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
Revenue
2,947
15,230
Cost of revenue
1,718
5,659
Sales and marketing
1,304
10,804
Research and development-Clinical Trials And Medical Affairs
343
3,020
Research and development-Product Development
205
1,848
Research and development-Digital
98
969
Research and development-Quality And Regulatory
266
1,733
General and administrative
2,744
21,353
Other segment items
-2,364
1,401
Net loss
-6,095
-28,755
Non-cash lease expense
119
679
Depreciation and amortization
171
983
Stock-based compensation
638
3,146
Provision for uncollectible accounts
-
2,847
Unrealized exchange gain (loss) and other
-
206
Unrealized exchange (gain) loss
-90
-
Provision for inventory
433
1,216
Change in fair value of warrant liabilities
-4,324
-12,800
Warrant inducement expense
4,145
-
Change in fair value of debt
750
3,615
Change in fair value of revenue interest financing and pipe conversion option
-
-9,090
Change in fair value of earn-out liabilities
-
1,059
Change in fair value of revenue interest financing
-1,820
-
Change in fair value of share obligation
-120
370
Interest paid on debt recorded at fair value
-
2,410
Loss on extinguishment of debt
-
-660
Issuance costs associated with warrants recorded at fair value
222
1,502
Accounts receivable
-365
-844
Inventory
-176
486
Prepaid expenses, other current and long-term assets
-172
-800
Lease liabilities
-73
-796
Accounts payable
-347
-3,141
Accrued expenses and other current liabilities
-1,363
-5,045
Net cash used in operating activities
-3,221
-28,946
Proceeds from private offerings, net of issuance costs
-
4,597
Proceeds from public offerings, net of issuance costs
-
13,578
Proceeds from equity line financing
-
795
Proceeds from warrant inducement, net of issuance costs
2,866
-
Net cash provided by financing activities
2,866
18,970
Net increase (decrease) in cash and cash equivalents and restricted cash
-355
-9,976
Cash and cash equivalents and restricted cash at beginning of period
5,742
15,718
Cash and cash equivalents and restricted cash at end of period
5,387
5,742
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
ALURW Cash Flow Sankey Diagram
Sankey diagram visualizing ALURW cash flow for the period
Proceeds from warrant
inducement, net of issuance...
$2,866K
Net cash provided by
financing activities
$2,866K
Net increase
(decrease) in cash and cash...
-$355K
Canceled cashflow
$2,866K
Warrant inducement
expense
$4,145K
Change in fair value of
revenue interest...
-$1,820K
Change in fair value of
debt
$750K
Stock-based compensation
$638K
Provision for inventory
$433K
Accounts receivable
-$365K
Issuance costs
associated with warrants...
$222K
Inventory
-$176K
Prepaid expenses, other
current and long-term...
-$172K
Depreciation and
amortization
$171K
Non-cash lease expense
$119K
Unrealized exchange (gain)
loss
-$90K
Net cash used in
operating activities
-$3,221K
Canceled cashflow
$9,101K
Revenue
$2,947K
Net loss
-$6,095K
Canceled cashflow
$2,947K
Change in fair value of
warrant liabilities
-$4,324K
Accrued expenses and
other current...
-$1,363K
Accounts payable
-$347K
Change in fair value of
share obligation
-$120K
Lease liabilities
-$73K
General and
administrative
$2,744K
Other segment items
-$2,364K
Cost of revenue
$1,718K
Sales and marketing
$1,304K
Research and
development-Clinical Trials And...
$343K
Research and
development-Quality And Regulatory
$266K
Research and
development-Product Development
$205K
Research and
development-Digital
$98K
Buy us a coffee